ARTICLE DOWNLOAD

Looking into the next decade of antithrombotic therapy for patients with atrial fibrillation and percutaneous coronary intervention

10$
ARTICLE DOWNLOAD

Looking into the next decade of antithrombotic therapy for patients with atrial fibrillation and percutaneous coronary intervention

10$

Benjamin E. Peterson & Deepak L. Bhatt 

Abstract

Patients with atrial fibrillation who undergo percutaneous coronary intervention are at increased risk for both coronary and cerebral thrombotic events. As a result, antithrombotic therapy for this patient population continues to pose a significant challenge. In this review, we discuss the development of warfarin triple therapy as the standard of care in the last century, the transition to dual therapy with warfarin and a P2Y12 inhibitor, the advent of NOACs, recent clinical trials, and new regimens with a NOAC and a P2Y12 inhibitor. We also discuss our current clinical practice, based on the available data.

Only units of this product remain
Year 2020
Language English
Format PDF
DOI 10.1007/s11239-020-02081-z